Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 16,390 | 16,932 | 0 |
| Operating Income | -16,390 | -16,932 | N/A |
| Interest Expense | 4,905 | 3,378 | 0 |
| Other Income | -5,762 | -31 | 0 |
| Pre-tax Income | -27,057 | -20,341 | 0 |
| Net Income Continuous | -27,057 | -20,341 | N/A |
| Net Income | $-27,057 | $-20,341 | $N/A |
| EPS Basic Total Ops | -4.80 | -3.60 | N/A |
| EPS Basic Continuous Ops | -4.74 | -3.56 | N/A |
| EPS Diluted Total Ops | -4.80 | -3.60 | N/A |
| EPS Diluted Continuous Ops | -4.74 | -3.56 | N/A |
| EBITDA(a) | $-16,390 | $-16,932 | $N/A |